Inventor · disambiguated record
Ana Castro Morera
Also filed as: CASTRO MORERA ANA
0 granted patents·9 pending applications·0 citations·filing 2007–2015
Files withNOSCIRA SA6CONSEJO SUPERIOR DE INVESTIG CIENTIFICAS (CSIC)1MEDINA PADILLA MIGUEL1NEUROPHARMA SA1
Top patents by PatentIndex Score
9 records- 0143US2011092591A1Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2009·Application pending·0 cites
- 0243US2009192204A1N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitorsNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0343US2009221647A1N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitorsNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0442US2014011835A1[1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseasesNOSCIRA SA·Filed 2013·Application pending·0 cites
- 0541US2009069430A1Dibenzene derivatives as calcium channel blockersNEUROPHARMA SA·Filed 2008·Application pending·0 cites
- 0641US2011306631A1Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancerMEDINA PADILLA MIGUEL·Filed 2009·Application pending·0 cites
- 0739US2010041665A1N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0838US2010267827A1Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disordersNOSCIRA SA·Filed 2007·Application pending·0 cites
- 0936US2017283378A1Indole derivatives for the prevention and/or treatment of diabetes and associated metabolic disordersCONSEJO SUPERIOR DE INVESTIG CIENTIFICAS (CSIC)·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ana Castro Morera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →